-

BlinkRx Welcomes Former Congressman Cedric Richmond as Senior Advisor

NEW YORK--(BUSINESS WIRE)--BlinkRx, the leading digital health company transforming access to prescription medications, today announced that former Congressman Cedric Richmond (D-LA) has joined BlinkRx as a Senior Advisor.

BlinkRx, the leading digital health company transforming access to prescription medications, today announced that former Congressman Cedric Richmond (D-LA) has joined BlinkRx as a Senior Advisor.

Share

Richmond brings decades of experience at the highest levels of public service, policy development, and strategic leadership. During his six terms in the U.S. House of Representatives, he served on the powerful House Ways and Means, Judiciary, and Homeland Security Committees, where he built a reputation for pragmatism and effectiveness. Notably, as Chairman of the Cybersecurity, Infrastructure Protection, and Innovation Subcommittee, Richmond led bipartisan efforts to modernize the nation's digital infrastructure and protect against cyber threats.

As the Chairman of the Congressional Black Caucus (CBC), Richmond prioritized economic equity, affordable housing, and criminal justice reform, playing a key role in the passage of the landmark, bipartisan FIRST STEP Act.

Following his congressional tenure, Richmond served as a Senior Advisor to President Biden and Director of the White House Office of Public Engagement. In this capacity, he acted as the primary liaison between the White House and key national stakeholders, including business leaders, civil rights organizations, and advocacy groups, helping to advance the administration’s healthcare and infrastructure agendas, including the historic Infrastructure Investment and Jobs Act.

In his role as Senior Advisor, Richmond will provide strategic guidance as BlinkRx continues to scale its platform and advance its mission of making the prescription drug system more accessible and affordable for all Americans.

“There is nothing more stressful and humiliating than getting to the pharmacy counter and realizing you can’t get the medication your doctor told you that you need. No American should experience that and I’m proud to work with Blink to make sure it never happens again,” said Richmond.

“Cedric is a proven leader who understands how to navigate hard problems and drive meaningful outcomes,” said Geoff Chaiken, Co-Founder and CEO of BlinkRx. “He brings a rare combination of policy expertise, real-world problem-solving, and a deep commitment to improving people’s lives. We’re thrilled to welcome him to BlinkRx and excited about the impact we can make together as we continue building a more patient-centered prescription drug system.”

“Cedric brings a perspective that’s incredibly valuable for BlinkRx and for the healthcare system more broadly,” said Matt Chaiken, Co-Founder and President of BlinkRx. “He understands how to align diverse stakeholders to take on entrenched problems, which will help turn big ideas into real solutions. We’re excited to work with him as we continue expanding BlinkRx’s impact and building smarter, more efficient prescription drug pathways for patients.”

About BlinkRx

BlinkRx is revolutionizing the pharmacy experience, using cutting-edge technology to dramatically improve patient access for branded medications. Patients enjoy affordable, transparent pricing, co-pay assistance, free home delivery, and personalized support.

Contacts

For media inquiries, please contact: Press@blinkrx.com

BlinkRx


Release Versions
Hashtags

Contacts

For media inquiries, please contact: Press@blinkrx.com

Social Media Profiles
More News From BlinkRx

NeuroVice Prescription Device for Seizure Oral Injury Protection Now Available at BlinkRx

NEW YORK--(BUSINESS WIRE)--BlinkRx, the industry’s leading prescription journey management platform, announced that the PATI (Protector Against Tongue Injury) device from NeuroVice is now available on the BlinkRx platform. Through BlinkRx, patients and caregivers can access the lowest available pricing, free home delivery, and personalized support for PATI. Epilepsy is the fourth leading neurological disorder, affecting about 65 million people worldwide and 3.4 million in the United States, wit...

BlinkRx Launches “Operation Access Now” to Accelerate and Scale Direct‑to‑Patient and Direct‑to‑Business Programs

NEW YORK--(BUSINESS WIRE)--BlinkRx, the nation's leading prescription lifecycle management platform, today announced the launch of Operation Access Now, a rapid deployment initiative that enables pharmaceutical manufacturers to build and launch direct-to-patient (DTP) and direct‑to‑business (DTB) channels that expand medication access and deliver pricing transparency in as little as 21 days. This program comes at a moment of growing urgency across the life sciences industry. As traditional acce...

BlinkRx is Now Offering neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

NEW YORK--(BUSINESS WIRE)--BlinkRx, the world’s most advanced patient access platform for branded medications, is excited to announce a new partnership with ARS Pharmaceuticals to offer neffy®, the needle-free epinephrine nasal spray, now available on its platform. neffy is the first and only needle-free treatment for severe allergic reactions, including life-threatening anaphylaxis for children and adults who weigh 30kgs (66lbs.) or more. Now, prescribed patients can conveniently access neffy...
Back to Newsroom